West Pharmaceutical Services, Inc. (WST) is a publicly traded Healthcare sector company. As of July 22, 2026, WST trades at $359.34 with a market cap of $24.89B and a P/E ratio of 47.79. WST moved +1.96% today. Year to date, WST is +30.57%; over the trailing twelve months it is +71.00%. Its 52-week range spans $187.43 to $367.66. Analyst consensus is strong buy with an average price target of $399.63. Rallies surfaces WST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
10 analysts cover WST: 0 strong buy, 9 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $399.63.
| Metric | Value |
|---|---|
| Price | $359.34 |
| Market Cap | $24.89B |
| P/E Ratio | 47.79 |
| EPS | $7.52 |
| Dividend Yield | 0.22% |
| 52-Week High | $367.66 |
| 52-Week Low | $187.43 |
| Volume | 464.70K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.22B |
| Net Income | $542.70M |
| Gross Margin | 36.28% |
10 analysts cover WST: 0 strong buy, 9 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $399.63.